A Pandora's box: Sustainable pharmaceutical supply

Medical Journal of Australia

Volumn 195, Issue 9, 2011, Pages 510-511

  Quilty, Simon ^a   Harris, Lisa M ^a   Kewley, Jacqueline ^a   Jones, Alison ^b   Pearce, Robert ^a   James, Rosemary ^a   McGain, Forbes ^c  

^a Hunter New England Local Health Network   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c WESTERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; DRUGS USED IN THE TREATMENT OF ADDICTION; GASTROINTESTINAL AGENT; HEPARIN; LOCAL ANESTHETIC AGENT; MINERAL; OPIATE; OXYTOCIN; PENICILLIN G; PROPOFOL; VITAMIN; ESSENTIAL DRUG;

ARTICLE; AUSTRALIA; COMMERCIAL PHENOMENA; DISASTER PLANNING; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG RECALL; DRUG SAFETY; DRUG SHORTAGE; EXPIRATION DATE; FLOODING; GOOD MANUFACTURING PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; INTERNATIONAL COOPERATION; NATURAL DISASTER; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; SHELF LIFE; HEALTH SERVICE; HUMAN; ORGANIZATION AND MANAGEMENT; PHARMACY;

AUSTRALIA; DISASTER PLANNING; DRUGS, ESSENTIAL; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONAL COOPERATION; PHARMACEUTICAL SERVICES;

EID: 84855168427     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.11150     Document Type: Article

References (12)

1. Steinbrook R. Drug shortages and public health. N Engl J Med 2009; 361: 1525-1527.
2. Larkin H. Drug shortage may be the worst in 30 years. Hosp Health Netw 2011; 85: 28-32.
3. American Society of Health-System Pharmacists. Drug Shortages Resource Center. http:/www.ashp.org/shortages (accessed Sep 2011).
4. Connelly P, Quinn BP. Manufacturing decline yields drug shortages. Science 2011; 333: 156-157.
5. Woo J, Wolfgang S, Batista H. The effect of globalization of drug manufacturing, production and sourcing and challenges for American drug safety. Clin Pharmacol Ther 2008; 83: 494-497.
6. Kuehn BM. As production goes global, drug supply faces greater risks to safety, quality. JAMA 2011; 306: 811-813.
7. Productivity Commission. Evaluation of the Pharmaceutical Industry Investment Program. Research report. Canberra: Ausinfo, 2003.
8. Avorn J. Coagulation and adulteration - building on science and policy lessons from 1905. N Engl J Med 2008; 358: 2429-2431.
9. Jensen V, Rappaport BA. The reality of drug shortages - the case of the injectable agent propofol. N Engl J Med 2010; 363: 806.
10. Sparling PF. Shortages of antibiotics, antivirals and vaccines threatens the public health [editorial]. Clin Infect Dis 2001; 33: 1502-1503.
11. McEvoy M, Smith W, D'Este C, et al. Cohort profile: the Hunter Community Study. Int J Epidemiol 2010; 36: 1452-1463.
12. Ford ES, Mokdad AH, Link MW, et al. Chronic disease in health emergencies: in the eye of the hurricane. Prev Chronic Dis 2006; 3: 1-7.